港股異動丨都市麗人漲超13% 觸及去年10月高位 年內累計上漲超45%
都市麗人(2298.HK)漲超13%,報0.375港元,觸及去年10月的高位,爲2023年8月以來新高。該股今年以來已累計上漲超45%。消息面上,都市麗人此前公佈,2024年錄得網上商品交易總額(GMV)約15.7億元,按年增長100%。公司副總裁兼首席財務官蔡瑋軒指,今年GMV目標與去年相若,意味著有望增長超過100%。公司去年全年派息1.6港仙,派息率約30%,目標未來派息率維持在相若水平。另外,都市麗人近日攜手中國社會福利基金會展開“麗人公益行”新疆站活動,向圖木舒克市捐贈5萬件優質內衣,並獲民政部與中國社會福利基金會的專題報道和高度肯定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.